The latest F-1* filing is at www.sec.gov/Archives/edgar/data/1567529/000114420413031877/v346162_f1a.htm .
*Foreign-company version of an S-1 filing.
Hard for me to handicap what a fair value is for this company since their drug targets and indications are perhaps a bit atypical (http://www.kamada.com/product-development.php?ID=7 ). Guess that can be a good or bad thing depending on your viewpoint.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.